Cargando…
Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy
[Image: see text] The extracellular signal-regulated kinase 5 (ERK5) signaling pathway is one of four conventional mitogen-activated protein (MAP) kinase pathways. Genetic perturbation of ERK5 has suggested that modulation of ERK5 activity may have therapeutic potential in cancer chemotherapy. This...
Autores principales: | Miller, Duncan C., Harnor, Suzannah J., Martin, Mathew P., Noble, Richard A., Wedge, Stephen R., Cano, Celine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108346/ https://www.ncbi.nlm.nih.gov/pubmed/37002872 http://dx.doi.org/10.1021/acs.jmedchem.3c00072 |
Ejemplares similares
-
Parallel Optimization
of Potency and Pharmacokinetics
Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain
Inhibitor
por: Miller, Duncan C., et al.
Publicado: (2022) -
Cyclin-Dependent
Kinase (CDK) Inhibitors: Structure–Activity
Relationships and Insights into the CDK-2 Selectivity of 6-Substituted
2-Arylaminopurines
por: Coxon, Christopher R., et al.
Publicado: (2016) -
Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation
por: Lochhead, Pamela A., et al.
Publicado: (2016) -
Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach
por: Miller, Duncan C., et al.
Publicado: (2018) -
Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors
por: Lochhead, Pamela A., et al.
Publicado: (2020)